FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

andrew bottomley

Research Profile

Concepts & Ideas

Disorders

Activities & Behaviors

Questionnaires

Procedures

Geographic Areas

Europe

Co-author Network

Publications

TOP 3
Francesca Martinelli; Tito Mendoza; David Osoba; Chantal Quinten; Bryce B Reeve; Jolie Ringash; Qiuling Shi; Martin J Taphoorn; Jurgen Vercauteren; Joachim Weis; andrew bottomley; Charles S Cleeland; Corneel Coens; Henning Flechtner; Carolyn C Gotay; Elfriede Greimel; Madeleine King; Joseph Schmucker-Von Koch; John T Maringwa
Examining the relationships among health-related quality-of-life indicators in cancer patients participating in clinical trials: a pooled study of baseline EORTC QLQ-C30 data.
John Maringwa; F Martinelli; David Osoba; C Quinten; B B Reeve; J Ringash; J Schmucker-Von Koch; R Stupp; Martin J B Taphoorn; M J Van Den Bent; J Weis; andrew bottomley; Charles S Cleeland; Corneel Coens; Henning Flechtner; Carolyn C Gotay; Elfriede Greimel; M King
Minimal clinically meaningful differences for the EORTC QLQ-C30 and EORTC QLQ-BN20 scales in brain cancer patients.
Dagmara Kuliś; María Arnott; andrew bottomley; Elfriede R Greimel; Michael Koller
Trends in translation requests and arising issues regarding cultural adaptation.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of andrew bottomley (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2011: Francesca Martinelli; Tito Mendoza; David Osoba; Chantal Quinten; Bryce B Reeve; Jolie Ringash; Qiuling Shi; Martin J Taphoorn; Jurgen Vercauteren; Joachim Weis; andrew bottomley; Charles S Cleeland; Corneel Coens; Henning Flechtner; Carolyn C Gotay; Elfriede Greimel; Madeleine King; Joseph Schmucker-Von Koch; John T Maringwa
Examining the relationships among health-related quality-of-life indicators in cancer patients participating in clinical trials: a pooled study of baseline EORTC QLQ-C30 data.
Expert review of pharmacoeconomics & outcomes research 2011;11(5):587-99.
2011: John Maringwa; F Martinelli; David Osoba; C Quinten; B B Reeve; J Ringash; J Schmucker-Von Koch; R Stupp; Martin J B Taphoorn; M J Van Den Bent; J Weis; andrew bottomley; Charles S Cleeland; Corneel Coens; Henning Flechtner; Carolyn C Gotay; Elfriede Greimel; M King
Minimal clinically meaningful differences for the EORTC QLQ-C30 and EORTC QLQ-BN20 scales in brain cancer patients.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2011;22(9):2107-12.
2011: Dagmara Kuliś; María Arnott; andrew bottomley; Elfriede R Greimel; Michael Koller
Trends in translation requests and arising issues regarding cultural adaptation.
Expert review of pharmacoeconomics & outcomes research 2011;11(3):307-14.
2011: Lily Claassens; Jan van Meerbeeck; Corneel Coens; Chantal Quinten; Irina Ghislain; Elizabeth K Sloan; Xin Shelly Wang; Galina Velikova; andrew bottomley
Health-related quality of life in non-small-cell lung cancer: an update of a systematic review on methodologic issues in randomized controlled trials.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2011;29(15):2104-20.
2010: Neil W Scott; Peter M Fayers; Neil K Aaronson; andrew bottomley; Alexander de Graeff; Mogens Groenvold; Chad Gundy; Michael Koller; Morten Aa Petersen; Mirjam A G Sprangers
Interpretation of differential item functioning analyses using external review.
Expert review of pharmacoeconomics & outcomes research 2010;10(3):253-8.
2010: Neil W Scott; Peter M Fayers; Neil K Aaronson; andrew bottomley; Alexander de Graeff; Mogens Groenvold; Chad Gundy; Michael Koller; Morten Aa Petersen; Mirjam A G Sprangers
Differential item functioning (DIF) analyses of health-related quality of life instruments using logistic regression.
Health and quality of life outcomes 2010;8():81.
2009: Edward Chow; andrew bottomley
Understanding the EORTC QLQ-BM22, the module for patients with bone metastases.
Expert review of pharmacoeconomics & outcomes research 2009;9(5):461-5.
2009: Neil W Scott; Peter M Fayers; Neil Aaronson; andrew bottomley; Alexander de Graeff; Mogens Groenvold; Chad Gundy; Michael Koller; Morten Aa Petersen; Mirjam A G Sprangers
The practical impact of differential item functioning analyses in a health-related quality of life instrument.
Quality of life research : an international journal of quality of life aspects of treatment, care and rehabilitation 2009;18(8):1125-30.
2009: Chantal Quinten; Corneel Coens; Murielle Mauer; Sylvie Comte; Mirjam A G Sprangers; Charles S Cleeland; David Osoba; Kristin Bjordal; andrew bottomley
Baseline quality of life as a prognostic indicator of survival: a meta-analysis of individual patient data from EORTC clinical trials.
The lancet oncology 2009;10(9):865-71.
2009: Kristin Harris; Edward Chow; Liying Zhang; Galina Velikova; Andrea Bezjak; Jackson Wu; Michael Barton; Orhan Sezer; Richard Eek; Jesmin Shafiq; Albert Yee; Mark Clemons; Michael Brundage; Peter Hoskin; Yvette van der Linden; Colin D Johnson; andrew bottomley
Patients' and health care professionals' evaluation of health-related quality of life issues in bone metastases.
European journal of cancer (Oxford, England : 1990) 2009;45(14):2510-8.
2009: andrew bottomley; Corneel Coens; Stefan Suciu; mario santinami; Willem Kruit; Alessandro Testori; Jeremy Marsden; Cornelis Punt; François Salès; Martin Gore; Rona Mackie; Zvonko Kusic; Reinhard Dummer; Poulam Patel; Dirk Schadendorf; Alain Spatz; Ulrich Keilholz; Alexander Eggermont
Adjuvant therapy with pegylated interferon alfa-2b versus observation in resected stage III melanoma: a phase III randomized controlled trial of health-related quality of life and symptoms by the European Organisation for Research and Treatment of Cancer Melanoma Group.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2009;27(18):2916-23.
2009: Edward Chow; Amanda Hird; Galina Velikova; Colin D Johnson; Linda Dewolf; Andrea Bezjak; Jackson Wu; Jesmin Shafiq; Orhan Sezer; Dimitrios Kardamakis; Yvette van der Linden; Brigette Ma; Monica Castro; Palmira Foro Arnalot; Sam Ahmedzai; Mark Clemons; Peter Hoskin; Albert Yee; Michael Brundage; andrew bottomley
The European Organisation for Research and Treatment of Cancer Quality of Life Questionnaire for patients with bone metastases: the EORTC QLQ-BM22.
European journal of cancer (Oxford, England : 1990) 2009;45(7):1146-52.
2009: Neil W Scott; Peter M Fayers; Neil Aaronson; andrew bottomley; Alexander de Graeff; Mogens Groenvold; Chad Gundy; Michael Koller; Morten Aa Petersen; Mirjam A G Sprangers
Differential item functioning (DIF) in the EORTC QLQ-C30: a comparison of baseline, on-treatment and off-treatment data.
Quality of life research : an international journal of quality of life aspects of treatment, care and rehabilitation 2009;18(3):381-8.
2009: andrew bottomley; Chantal Quinten; Corneel Coens; Francesca Martinelli; Murielle Mauer; John Maringwa; Charles S Cleeland; Henning Flechtner; Carolyn Gotay; Eva Greimel; Madeleine King; David Osoba; Martin J B Taphoorn; Bryce B Reeve; Jolie Ringash; Joseph Schmucker-Von Koch; Joachim Weis
Making better use of existing cancer data: Patient Reported Outcomes and Behavioural Evidence: a new international initiative.
European journal of cancer care 2009;18(2):105-7.
2009: Neil W Scott; Peter M Fayers; Neil Aaronson; andrew bottomley; Alexander de Graeff; Mogens Groenvold; Chad Gundy; Michael Koller; Morten Aa Petersen; Mirjam A G Sprangers
A simulation study provided sample size guidance for differential item functioning (DIF) studies using short scales.
Journal of clinical epidemiology 2009;62(3):288-95.
2009: andrew bottomley
Health-related quality of life and cancer.
Expert review of pharmacoeconomics & outcomes research 2009;9(1):9-11.
2009: andrew bottomley; Dave Jones; Lily Claassens
Patient-reported outcomes: assessment and current perspectives of the guidelines of the Food and Drug Administration and the reflection paper of the European Medicines Agency.
European journal of cancer (Oxford, England : 1990) 2009;45(3):347-53.
2009: Ben Slotman; Murielle E Mauer; andrew bottomley; Corinne Faivre-Finn; Gijs W P M Kramer; Elaine Rankin; Michael Snee; Matthew Hatton; Pieter E Postmus; Laurence Collette; Suresh Senan
Prophylactic cranial irradiation in extensive disease small-cell lung cancer: short-term health-related quality of life and patient reported symptoms: results of an international Phase III randomized controlled trial by the EORTC Radiation Oncology and Lung Cancer Groups.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2009;27(1):78-84.
2008: Murielle E Mauer; andrew bottomley; Martin J B Taphoorn
Evaluating health-related quality of life and symptom burden in brain tumour patients: instruments for use in experimental trials and clinical practice.
Current opinion in neurology 2008;21(6):745-53.
2008: George van Andel; andrew bottomley; Sophie D Fosså; Fabio Efficace; Corneel Coens; Stephane Guerif; Howard Kynaston; Massimiliano Di Marco; George Thalmann; Atif Akdas; Sven D'Haese; Neil K Aaronson
An international field study of the EORTC QLQ-PR25: a questionnaire for assessing the health-related quality of life of patients with prostate cancer.
European journal of cancer (Oxford, England : 1990) 2008;44(16):2418-24.
2008: andrew bottomley; Channa Debruyne; Enriqueta Felip; Michael Millward; Luc Thiberville; Giannicola D'Addario; Lisa Rome; Petr Zatloukal; Corneel Coens; Giuseppe Giaccone
Symptom and quality of life results of an international randomised phase III study of adjuvant vaccination with Bec2/BCG in responding patients with limited disease small-cell lung cancer.
European journal of cancer (Oxford, England : 1990) 2008;44(15):2178-84.
2008: andrew bottomley
The journey of health-related quality of life assessment.
The lancet oncology 2008;9(9):906.
2008: M E Mauer; andrew bottomley; C Coens
Statistical methodology is crucial in prognostic factor analysis of health-related quality of life.
Quality of life research : an international journal of quality of life aspects of treatment, care and rehabilitation 2008;17(7):1043-4; discussion 1045-6.
2008: Neil W Scott; Peter M Fayers; Neil Aaronson; andrew bottomley; Alexander de Graeff; Mogens Groenvold; Michael Koller; Morten Aa Petersen; Mirjam A G Sprangers
The relationship between overall quality of life and its subdimensions was influenced by culture: analysis of an international database.
Journal of clinical epidemiology 2008;61(8):788-95.
2008: Murielle E Mauer; andrew bottomley; Laurence Collette; Ben Slotman
Palliative-care trials: how best to publish findings?
The lancet oncology 2008;9(5):411-2.
2008: Fabio Efficace; Pasquale F Innominato; Georg Bjarnason; Corneel Coens; Yves Humblet; Salvatore Tumolo; Dominique Genet; Marco Tampellini; andrew bottomley; Carlo Garufi; Christian Focan; Sylvie Giacchetti; Francis Lévi
Validation of patient's self-reported social functioning as an independent prognostic factor for survival in metastatic colorectal cancer patients: results of an international study by the Chronotherapy Group of the European Organisation for Research and Treatment of Cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2008;26(12):2020-6.
2008: Carolyn C Gotay; Crissy Kawamoto; andrew bottomley; Fabio Efficace
The prognostic significance of patient-reported outcomes in cancer clinical trials.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2008;26(8):1355-63.
2008: Eylem Sahin Cankurtaran; Elvan Ozalp; Haldun Soygur; S Ozer; D I Akbiyik; andrew bottomley
Understanding the reliability and validity of the EORTC QLQ-C30 in Turkish cancer patients.
European journal of cancer care 2008;17(1):98-104.
2007: andrew bottomley; Corneel Coens; Fabio Efficace; Rabab Mohamed Gaafar; Christian Manegold; Sjaak A Burgers; mark vincent; Catherine Legrand; Jan P van Meerbeeck
Symptoms and patient-reported well-being: do they predict survival in malignant pleural mesothelioma? A prognostic factor analysis of EORTC-NCIC 08983: randomized phase III study of cisplatin with or without raltitrexed in patients with malignant pleural mesothelioma.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2007;25(36):5770-6.
2007: Murielle E L Mauer; Martin J B Taphoorn; andrew bottomley; Corneel Coens; Fabio Efficace; Marc Sanson; Alba A Brandes; Carin C D van der Rijt; Hans J J A Bernsen; Marc Frénay; Cees C Tijssen; Denis Lacombe; Martin J van den Bent
Prognostic value of health-related quality-of-life data in predicting survival in patients with anaplastic oligodendrogliomas, from a phase III EORTC brain cancer group study.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2007;25(36):5731-7.
2007: Martin J B Taphoorn; Martin J van den Bent; Murielle E L Mauer; Corneel Coens; Jean-Yves Delattre; Alba A Brandes; Peter A E Sillevis Smitt; Hans J J A Bernsen; Marc Frénay; Cees C Tijssen; Denis Lacombe; Anouk Allgeier; andrew bottomley
Health-related quality of life in patients treated for anaplastic oligodendroglioma with adjuvant chemotherapy: results of a European Organisation for Research and Treatment of Cancer randomized clinical trial.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2007;25(36):5723-30.
2007: andrew bottomley; Neil K Aaronson
International perspective on health-related quality-of-life research in cancer clinical trials: the European Organisation for Research and Treatment of Cancer experience.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2007;25(32):5082-6.
2007: Pernilla Lagergren; Peter M Fayers; Thierry Conroy; Hubert J Stein; Orhan Sezer; Richard Hardwick; Eva Hammerlid; andrew bottomley; Eric Van Cutsem; Jane M Blazeby
Clinical and psychometric validation of a questionnaire module, the EORTC QLQ-OG25, to assess health-related quality of life in patients with cancer of the oesophagus, the oesophago-gastric junction and the stomach.
European journal of cancer (Oxford, England : 1990) 2007;43(14):2066-73.
2007: Murielle E L Mauer; Roger Stupp; Martin J B Taphoorn; Corneel Coens; David Osoba; Christine Marosi; R Wong; O de Witte; J G Cairncross; Fabio Efficace; René-Olivier Mirimanoff; Peter A Forsyth; Martin J van den Bent; M Weller; andrew bottomley
The prognostic value of health-related quality-of-life data in predicting survival in glioblastoma cancer patients: results from an international randomised phase III EORTC Brain Tumour and Radiation Oncology Groups, and NCIC Clinical Trials Group study.
British journal of cancer 2007;97(3):302-7.
2007: Michael Koller; Neil K Aaronson; Jane M Blazeby; andrew bottomley; Linda Dewolf; Peter M Fayers; Colin D Johnson; John Ramage; Neil Scott; Karen West
Translation procedures for standardised quality of life questionnaires: The European Organisation for Research and Treatment of Cancer (EORTC) approach.
European journal of cancer (Oxford, England : 1990) 2007;43(12):1810-20.
2007: Fabio Efficace; David Osoba; Carolyn C Gotay; Mirjam Sprangers; Corneel Coens; andrew bottomley
Has the quality of health-related quality of life reporting in cancer clinical trials improved over time? Towards bridging the gap with clinical decision making.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2007;18(4):775-81.
2007: Neil W Scott; Peter M Fayers; Neil Aaronson; andrew bottomley; Alexander de Graeff; Mogens Groenvold; M Koller; Morten Aa Petersen; Mirjam A G Sprangers
The use of differential item functioning analyses to identify cultural differences in responses to the EORTC QLQ-C30.
Quality of life research : an international journal of quality of life aspects of treatment, care and rehabilitation 2007;16(1):115-29.
2007: Anne Brédart; Corneel Coens; Neil Aaronson; Wei-Chu Chie; Fabio Efficace; Thierry Conroy; Jane M Blazeby; Eva Hammerlid; M Costantini; F Joly; Simon Schraub; Orhan Sezer; Juan Ignacio Arraras; C Rodary; A Costantini; M Mehlitz; Darius Razavi; andrew bottomley
Determinants of patient satisfaction in oncology settings from European and Asian countries: preliminary results based on the EORTC IN-PATSAT32 questionnaire.
European journal of cancer (Oxford, England : 1990) 2007;43(2):323-30.
2006: Fabio Efficace; andrew bottomley; Egbert F Smit; Pilar Lianes; Catherine Legrand; Channa Debruyne; Franz Schramel; Hans J M Smit; Rabab Mohamed Gaafar; Bonne Biesma; Christian Manegold; Corneel Coens; Giuseppe Giaccone; Jan P van Meerbeeck
Is a patient's self-reported health-related quality of life a prognostic factor for survival in non-small-cell lung cancer patients? A multivariate analysis of prognostic factors of EORTC study 08975.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2006;17(11):1698-704.
2006: Neil W Scott; Peter M Fayers; andrew bottomley; Neil Aaronson; Alexander de Graeff; Mogens Groenvold; M Koller; Morten Aa Petersen; Mirjam A G Sprangers
Comparing translations of the EORTC QLQ-C30 using differential item functioning analyses.
Quality of life research : an international journal of quality of life aspects of treatment, care and rehabilitation 2006;15(6):1103-15; discussion 1117-20.
2006: andrew bottomley; Fabio Efficace
Predicting survival in advanced cancer patients: is it possible with patient-reported health status data?
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2006;17(7):1037-8.
2006: andrew bottomley; Rabab Mohamed Gaafar; Rabab Gaafa; Christian Manegold; Sjaak A Burgers; Corneel Coens; Catherine Legrand; mark vincent; Giuseppe Giaccone; Jan P van Meerbeeck
Short-term treatment-related symptoms and quality of life: results from an international randomized phase III study of cisplatin with or without raltitrexed in patients with malignant pleural mesothelioma: an EORTC Lung-Cancer Group and National Cancer Institute, Canada, Intergroup Study.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2006;24(9):1435-42.
2006: Mogens Groenvold; Morten Aa Petersen; Neil Aaronson; Juan Ignacio Arraras; Jane M Blazeby; andrew bottomley; Peter M Fayers; Alexander de Graeff; Eva Hammerlid; Stein Kaasa; Mirjam A G Sprangers; Jakob B Bjorner
EORTC QLQ-C15-PAL: the new standard in the assessment of health-related quality of life in advanced cancer?
Palliative medicine 2006;20(2):59-61.
2006: E Chow; P Hoskin; Y van der Linden; andrew bottomley; Galina Velikova
Quality of life and symptom end points in palliative bone metastases trials.
Clinical oncology (Royal College of Radiologists (Great Britain)) 2006;18(1):67-9.
2006: Patrizia Pugliese; Maria Perrone; Enrica Nisi; Carlo Garufi; Diana Giannarelli; andrew bottomley; Edmondo Terzoli
An integrated psychological strategy for advanced colorectal cancer patients.
Health and quality of life outcomes 2006;4():9.
2006: Fabio Efficace; andrew bottomley; Corneel Coens; Kristel van Steen; Thierry Conroy; Patrick Schöffski; Hans Schmoll; Eric Van Cutsem; Claus-Henning Köhne
Does a patient's self-reported health-related quality of life predict survival beyond key biomedical data in advanced colorectal cancer?
European journal of cancer (Oxford, England : 1990) 2006;42(1):42-9.
2006: Mogens Groenvold; Morten Aa Petersen; Neil Aaronson; Juan Ignacio Arraras; Jane M Blazeby; andrew bottomley; Peter M Fayers; Alexander de Graeff; Eva Hammerlid; Stein Kaasa; Mirjam A G Sprangers; Jakob B Bjorner
The development of the EORTC QLQ-C15-PAL: a shortened questionnaire for cancer patients in palliative care.
European journal of cancer (Oxford, England : 1990) 2006;42(1):55-64.
2005: Martin J B Taphoorn; Roger Stupp; Corneel Coens; David Osoba; Rolf-Dieter Kortmann; Martin J van den Bent; Warren Mason; René-Olivier Mirimanoff; Brigitta Baumert; Elizabeth Eisenhauer; Peter A Forsyth; andrew bottomley
Health-related quality of life in patients with glioblastoma: a randomised controlled trial.
The lancet oncology 2005;6(12):937-44.
2005: Corneel Coens; andrew bottomley; Fabio Efficace; Henning Flechtner; Neil Aaronson
Variability and sample size requirements for health-related quality-of-life measures: understanding the challenges facing investigators.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2005;23(33):8541-2; author reply 8542-3.
2005: Jan P van Meerbeeck; Rabab Mohamed Gaafar; Christian Manegold; Rob J van Klaveren; Eric A Van Marck; mark vincent; Catherine Legrand; andrew bottomley; Channa Debruyne; Giuseppe Giaccone
Randomized phase III study of cisplatin with or without raltitrexed in patients with malignant pleural mesothelioma: an intergroup study of the European Organisation for Research and Treatment of Cancer Lung Cancer Group and the National Cancer Institute of Canada.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2005;23(28):6881-9.
2005: Anne Brédart; andrew bottomley; Jane M Blazeby; Thierry Conroy; Corneel Coens; Sven D'haese; Wei-Chu Chie; Eva Hammerlid; Juan Ignacio Arraras; Fabio Efficace; C Rodary; Simon Schraub; M Costantini; A Costantini; F Joly; Orhan Sezer; Darius Razavi; M Mehlitz; M Bielska-Lasota; Neil Aaronson
An international prospective study of the EORTC cancer in-patient satisfaction with care measure (EORTC IN-PATSAT32).
European journal of cancer (Oxford, England : 1990) 2005;41(14):2120-31.
2005: andrew bottomley; Henning Flechtner; Fabio Efficace; Veerle Vanvoorden; Corneel Coens; Patrick Therasse; Galina Velikova; Jane M Blazeby; Elfriede Greimel
Health related quality of life outcomes in cancer clinical trials.
European journal of cancer (Oxford, England : 1990) 2005;41(12):1697-709.
2005: andrew bottomley; Patrick Therasse; Martine Piccart; Fabio Efficace; Corneel Coens; Carolyn C Gotay; Marzena Welnicka-Jaskiewicz; Louis Mauriac; Jaroslaw Dyczka; Tanja Cufer; Michail R Lichinitser; Jan H Schornagel; Hervé Bonnefoi; Lois Shepherd
Health-related quality of life in survivors of locally advanced breast cancer: an international randomised controlled phase III trial.
The lancet oncology 2005;6(5):287-94.
2005: Fabio Efficace; andrew bottomley
Toward a clearer understanding of the prognostic value of health-related quality-of-life parameters in breast cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2005;23(6):1335-6; author reply 1336.
2004: Laurence Collette; George van Andel; andrew bottomley; Gosse O N Oosterhof; Walter Albrecht; Theo M de Reijke; Sophie D Fossà
Is baseline quality of life useful for predicting survival with hormone-refractory prostate cancer? A pooled analysis of three studies of the European Organisation for Research and Treatment of Cancer Genitourinary Group.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2004;22(19):3877-85.
2004: Jane M Blazeby; Thierry Conroy; andrew bottomley; Craig W Vickery; Juan Ignacio Arraras; Orhan Sezer; J Moore; M Koller; N S Turhal; R Stuart; Eric Van Cutsem; Sven D'haese; Corneel Coens
Clinical and psychometric validation of a questionnaire module, the EORTC QLQ-STO 22, to assess quality of life in patients with gastric cancer.
European journal of cancer (Oxford, England : 1990) 2004;40(15):2260-8.
2004: Fabio Efficace; Patrick Therasse; Martine J Piccart; Corneel Coens; Kristel van Steen; Marzena Welnicka-Jaskiewicz; Tanja Cufer; Jaroslaw Dyczka; Michail R Lichinitser; Lois Shepherd; Hanneke de Haes; Mirjam A G Sprangers; andrew bottomley
Health-related quality of life parameters as prognostic factors in a nonmetastatic breast cancer population: an international multicenter study.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2004;22(16):3381-8.
2004: andrew bottomley; Laura Biganzoli; Tanja Cufer; Robert E Coleman; Corneel Coens; Fabio Efficace; Hilary Calvert; Teresa Gamucci; Chris Twelves; Pierre Fargeot; Martine Piccart
Randomized, controlled trial investigating short-term health-related quality of life with doxorubicin and paclitaxel versus doxorubicin and cyclophosphamide as first-line chemotherapy in patients with metastatic breast cancer: European Organization for Research and Treatment of Cancer Breast Cancer Group, Investigational Drug Branch for Breast Cancer and the New Drug Development Group Study.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2004;22(13):2576-86.
2004: Sven D'haese; andrew bottomley
Short- and long-term HRQOL issues following brachytherapy for prostate cancer.
Expert review of pharmacoeconomics & outcomes research 2004;4(3):277-86.
2004: Alessandro Marco Minisini; Gul Atalay; andrew bottomley; Fabio Puglisi; Martine Piccart; Laura Biganzoli
What is the effect of systemic anticancer treatment on cognitive function?
The lancet oncology 2004;5(5):273-82.
2004: Asuman Guzelant; Tuncay Goksel; S Ozkok; Sezai Tasbakan; T Aysan; andrew bottomley
The European Organization for Research and Treatment of Cancer QLQ-C30: an examination into the cultural validity and reliability of the Turkish version of the EORTC QLQ-C30.
European journal of cancer care 2004;13(2):135-44.
2004: Fabio Efficace; Laura Biganzoli; Martine Piccart; Corneel Coens; Kristel van Steen; Tanja Cufer; R E Coleman; Hilary Calvert; Teresa Gamucci; Chris Twelves; Pierre Fargeot; andrew bottomley
Baseline health-related quality-of-life data as prognostic factors in a phase III multicentre study of women with metastatic breast cancer.
European journal of cancer (Oxford, England : 1990) 2004;40(7):1021-30.
2004: Fabio Efficace; andrew bottomley; Veerle Vanvoorden; Jane M Blazeby
Methodological issues in assessing health-related quality of life of colorectal cancer patients in randomised controlled trials.
European journal of cancer (Oxford, England : 1990) 2004;40(2):187-97.
2003: Fabio Efficace; andrew bottomley; David Osoba; Carolyn C Gotay; Henning Flechtner; Sven D'haese; Alfredo Zurlo
Beyond the development of health-related quality-of-life (HRQOL) measures: a checklist for evaluating HRQOL outcomes in cancer clinical trials--does HRQOL evaluation in prostate cancer research inform clinical decision making?
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2003;21(18):3502-11.
2003: Vassilis E Kouloulias; George K Matsopoulos; John R Kouvaris; Costas E Dardoufas; andrew bottomley; Maria Varela; Nikolaos K Uzunoglu; Christos Antypas; Anna Metafa; Antzela Moulopoulos; Panagiotis Sandilos; Lambros Vlahos
Radiotherapy in conjunction with intravenous infusion of 180 mg of disodium pamidronate in management of osteolytic metastases from breast cancer: clinical evaluation, biochemical markers, quality of life, and monitoring of recalcification using assessments of gray-level histogram in plain radiographs.
International journal of radiation oncology, biology, physics 2003;57(1):143-57.
2003: andrew bottomley; Fabio Efficace; Ronald Thomas; Veerle Vanvoorden; Sam H Ahmedzai
Health-related quality of life in non-small-cell lung cancer: methodologic issues in randomized controlled trials.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2003;21(15):2982-92.
2003: Elfriede Greimel; andrew bottomley; Ann Cull; A-C Waldenstrom; Juan Ignacio Arraras; L Chauvenet; Bernhard Holzner; K Kuljanic; J Lebrec; Sven D'haese
An international field study of the reliability and validity of a disease-specific questionnaire module (the QLQ-OV28) in assessing the quality of life of patients with ovarian cancer.
European journal of cancer (Oxford, England : 1990) 2003;39(10):1402-8.
2003: Jane M Blazeby; Thierry Conroy; Eva Hammerlid; Peter M Fayers; Orhan Sezer; M Koller; Juan Ignacio Arraras; andrew bottomley; Craig W Vickery; Pierre-Luc Etienne; Derek Alderson
Clinical and psychometric validation of an EORTC questionnaire module, the EORTC QLQ-OES18, to assess quality of life in patients with oesophageal cancer.
European journal of cancer (Oxford, England : 1990) 2003;39(10):1384-94.
2003: andrew bottomley; Ronald Thomas; Kristel van Steen; Henning Flechtner; Alexander de Graeff
Guidelines for the use of epoetin: have quality-of-life benefits been proven?
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2003;21(11):2223; author reply 2224-5.
2003: Fabio Efficace; andrew bottomley; Jane M Blazeby
Randomized clinical trial comparing quality of life after straight and pouch coloanal reconstruction (Br J Surg 2003; 89: 1108-1117).
The British journal of surgery 2003;90(5):594-5.
2003: Sophie D Fosså; Ronald de Wit; J Trevor Roberts; Peter M Wilkinson; P H M De Mulder; Graham M Mead; Pat Cook; Linda de Prijck; Sally P Stenning; Neil K Aaronson; andrew bottomley; Laurence Collette
Quality of life in good prognosis patients with metastatic germ cell cancer: a prospective study of the European Organization for Research and Treatment of Cancer Genitourinary Group/Medical Research Council Testicular Cancer Study Group (30941/TE20).
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2003;21(6):1107-18.
2003: andrew bottomley; Veerle Vanvoorden; Henning Flechtner; Patrick Therasse
The challenges and achievements involved in implementing Quality of Life research in cancer clinical trials.
European journal of cancer (Oxford, England : 1990) 2003;39(3):275-85.
2003: Fabio Efficace; andrew bottomley; George van Andel
Health related quality of life in prostate carcinoma patients: a systematic review of randomized controlled trials.
Cancer 2003;97(2):377-88.
2003: Henning Flechtner; andrew bottomley
Fatigue and quality of life: lessons from the real world.
The oncologist 2003;8 Suppl 1():5-9.
2003: Fabio Efficace; andrew bottomley
Assessing HRQOL: a neglected issue for high-grade glioma.
The lancet oncology 2003;4(1):11-2.
2002: Kristel van Steen; Desmond Curran; Jocelyn Kramer; Geert Molenberghs; Ann Van Vreckem; andrew bottomley; Richard Sylvester
Multicollinearity in prognostic factor analyses using the EORTC QLQ-C30: identification and impact on model selection.
Statistics in medicine 2002;21(24):3865-84.
2002: Anne Brédart; andrew bottomley
Treatment satisfaction as an outcome measure in cancer clinical treatment trials.
Expert review of pharmacoeconomics & outcomes research 2002;2(6):597-606.
2002: andrew bottomley; Patrick Therasse
Quality of life in patients undergoing systemic therapy for advanced breast cancer.
The lancet oncology 2002;3(10):620-8.
2002: Fabio Efficace; andrew bottomley
Do quality-of-life randomized clinical trials support clinicians in their decision-making?
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2002;20(19):4126-7; author reply 4127.
2002: andrew bottomley; Ronald Thomas; Kristel van Steen; Henning Flechtner; Benjamin Djulbegovic
Erythropoietin improves quality of life--a response.
The lancet oncology 2002;3(9):527.
2002: Fabio Efficace; andrew bottomley
Health related quality of life assessment methodology and reported outcomes in randomised controlled trials of primary brain cancer patients.
European journal of cancer (Oxford, England : 1990) 2002;38(14):1824-31.
2002: andrew bottomley; S Vachalec; Kristin Bjordal; Jane M Blazeby; Henning Flechtner; P Ruyskart
The development and utilisation of the European Organisation for research and treatment of cancer quality of life group item bank.
European journal of cancer (Oxford, England : 1990) 2002;38(12):1611-4.
2002: andrew bottomley; Fabio Efficace; Peter M Fayers
Standards are needed for quality of life clinical trials.
BMJ (Clinical research ed.) 2002;324(7346):1156.
2002: andrew bottomley
Metastatic colorectal cancer: treatment challenges and quality of life.
Lancet 2002;359(9317):1537-8.
2002: andrew bottomley; Ronald Thomas; Kristel van Steen; Henning Flechtner; Benjamin Djulbegovic
Human recombinant erythropoietin and quality of life: a wonder drug or something to wonder about?
The lancet oncology 2002;3(3):145-53.
2002: Peter M Fayers; andrew bottomley
Quality of life research within the EORTC-the EORTC QLQ-C30. European Organisation for Research and Treatment of Cancer.
European journal of cancer (Oxford, England : 1990) 2002;38 Suppl 4():S125-33.
2002: Henning Flechtner; andrew bottomley
Fatigue assessment in cancer clinical trials.
Expert review of pharmacoeconomics & outcomes research 2002;2(1):67-76.
2002: Fabio Efficace; andrew bottomley; Gary Collins
Quality of life in breast cancer patients: measurement issues in cancer clinical trials.
Expert review of pharmacoeconomics & outcomes research 2002;2(1):57-65.
2002: andrew bottomley
The cancer patient and quality of life.
The oncologist 2002;7(2):120-5.
2001: Elfriede Greimel; andrew bottomley
Quality of life issues in gynecological cancer.
Expert review of pharmacoeconomics & outcomes research 2001;1(1):93-8.
2000: J C J M de Haes; Desmond Curran; T Young; andrew bottomley; Henning Flechtner; Neil Aaronson; Jane M Blazeby; Kristin Bjordal; Yvonne Brandberg; Elfriede Greimel; J Maher; Mirjam Sprangers; Ann Cull
Quality of life evaluation in oncological clinical trials - the EORTC model. The EORTC Quality of Life Study Group.
European journal of cancer (Oxford, England : 1990) 2000;36(7):821-5.
1998: Carolyn C Gotay; andrew bottomley
Providing psycho-social support by telephone: what is its potential in cancer patients?
European journal of cancer care 1998;7(4):225-31.
1998: andrew bottomley
Anxiety and the adult cancer patient.
European journal of cancer care 1998;7(4):217-24.
1998: andrew bottomley
Psychotherapy groups and cancer patient survival: chasing fool's gold?
European journal of cancer care 1998;7(3):192-6.
1998: andrew bottomley
Depression in cancer patients: a literature review.
European journal of cancer care 1998;7(3):181-91.
1998: andrew bottomley; R Thomas
Self help groups and professionally conducted group interventions are different.
BMJ (Clinical research ed.) 1998;316(7133):781.
1998: andrew bottomley
Group cognitive behavioural therapy with cancer patients: the views of women participants on a short-term intervention.
European journal of cancer care 1998;7(1):23-30.
1997: andrew bottomley
Psychosocial problems in cancer care: a brief review of common problems.
Journal of psychiatric and mental health nursing 1997;4(5):323-31.
1997: andrew bottomley
To randomise or not to randomise: methodological pitfalls of the RCT design in psychosocial intervention studies.
European journal of cancer care 1997;6(3):222-30.
1997: andrew bottomley
Where are we now? Evaluating two decades of group interventions with adult cancer patients.
Journal of psychiatric and mental health nursing 1997;4(4):251-65.
1997: andrew bottomley; L Jones
Breast cancer care: women's experience.
European journal of cancer care 1997;6(2):124-32.
1997: andrew bottomley; L Jones
Social support and the cancer patient--a need for clarity.
European journal of cancer care 1997;6(1):72-7.
1997: andrew bottomley
Cancer support groups--are they effective?
European journal of cancer care 1997;6(1):11-7.
1997: andrew bottomley
Methodology for assessing the prevalence of angina in primary care using practice based information in northern England.
Journal of epidemiology and community health 1997;51(1):87-9.
1996: andrew bottomley
Group cognitive behavioural therapy interventions with cancer patients: a review of the literature.
European journal of cancer care 1996;5(3):143-6.
1995: andrew bottomley
The development of the Bottomley Cancer Social Support Scale.
European journal of cancer care 1995;4(3):127-32.